New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
11:58 EDTTMO, ILMNNew China rule prompts BGI to suspend trisomy testing, GenomeWeb says
BGI said a recent announcement from Chinese officials that genetic tests should be regulated has prompted the company to work with its collaborators to suspend the clinical application of its non-invasive fetal trisomy test in mainland China, according to GenomeWeb. Other providers of sequencing-based trisomy testing products, including Illumina (ILMN) and Thermo Fisher-owned (TMO) Life Technologies, declined to comment on the regulation notice, the report stated. The Fly notes that Illumina announced in January of 2010 that BGI had purchased 128 HiSeq 2000 sequencing systems. Illumina said at that time that revenue related to the sale of those instruments was expected to be recognized over the next three years. Reference Link
News For ILMN;TMO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 31, 2015
09:23 EDTILMNNextSeq CN500 receives premarket clearance from Chinese FDA
Subscribe for More Information
March 18, 2015
08:33 EDTILMNTrovagene appoints Matthew Posard as Chief Commercial Officer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use